1)Birchwood M, Todd P, Jackson C:Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 172:53-59, 1998
2)Fusar-Poli P, McGorry PD, Kane JM:Improving outcomes of first-episode psychosis:an overview. World Psychiatry 16:251-265, 2017
3)McCrone P, Craig TK, Power P, et al:Cost-effectiveness of an early intervention service for people with psychosis. Br J Psychiatry 196:377-382, 2010
4)Addington DE, McKenzie E, Norman R, et al:Essential evidence-based components of first-episode psychosis services. Psychiatr Serv 64:452-457, 2013
5)National Institute for Health and Care Excellence:Psychosis and schizophrenia in adults:Prevention and management. National Institute for Health and Care Excellence, London, 2014
6)Bertelsen M, Jeppesen P, Petersen L, et al:Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness:the OPUS trial. Arch Gen Psychiatry 65:762-771, 2008
7)Gafoor R, Nitsch D, McCrone P, et al:Effect of early intervention on 5-year outcome in non-affective psychosis. Br J Psychiatry 196:372-376, 2010
8)Chang WC, Kwong VW, Chan GH, et al:Prediction of functional remission in first-episode psychosis:12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong. Schizophr Res 173:79-83, 2016
9)Malla A, Joober R, Iyer S, et al:Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis:a randomized single blind clinical trial. World Psychiatry 16:278-286, 2017
10)Albert N, Melau M, Jensen H, et al:Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis:randomised, superiority, parallel group trial in Denmark(OPUS II). BMJ 356:i6681, 2017
11)Austin SF, Mors O, Budtz-Jorgensen E, et al:Long-term trajectories of positive and negative symptoms in first episode psychosis:A 10year follow-up study in the OPUS cohort. Schizophr Res 168:84-91, 2015
12)Fowler D, Hodgekins J, French P, et al:Social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis(SUPEREDEN3):a single-blind, randomised controlled trial. Lancet Psychiatry 5:41-50, 2018
13)Ciompi L and Hoffmann H:Soteria Berne:an innovative milieu therapeutic approach to acute schizophrenia based on the concept of affect-logic. World Psychiatry 3:140-146, 2004
14)Morrison AP, Turkington D, Pyle M, et al:Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs:a single-blind randomised controlled trial. Lancet 383:1395-1403, 2014
15)Morrison AP, Law H, Carter L, et al:Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis:a randomised controlled pilot and feasibility study. Lancet Psychiatry 5:411-423, 2018
16)Leucht S, Cipriani A, Spineli L, et al:Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia:a multiple-treatments meta-analysis. Lancet 382:951-962, 2013
17)Murray RM, Quattrone D, Natesan S, et al:Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? Br J Psychiatry 209:361-365, 2016
18)Tiihonen J, Tanskanen A, Taipale H:20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia. Am J Psychiatry 175:765-773, 2018
19)Wunderink L, Nieboer RM, Wiersma D, et al:Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy:long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry 70:913-920, 2013
20)松本和紀:寛解を維持している初回エピソード統合失調症における抗精神病薬の中止.臨床精神薬理 21:415-418, 2018
21)桂雅宏,阿部光一,國分恭子,他:ARMSへの早期介入—議論の整理と海外ガイドラインの紹介.精神医学 58:571-579, 2016
22)松本和紀:精神病性障害におけるスペクトラム.精神科診断学 9:96-102, 2016
23)van Os J, Guloksuz S:A critique of the “ultra-high risk” and “transition” paradigm. World Psychiatry 16:200-206, 2017
24)Yung AR, Nelson B, Thompson A, et al:The psychosis threshold in Ultra High Risk(prodromal)research:is it valid? Schizophr Res 120:1-6, 2010
25)松本和紀:統合失調症の初期症状—これまでの研究概念の概観.精神科治療学 33:79-85, 2018
26)松本和紀,濱家由美子,冨本和歩:ARMS(アットリスク精神状態)に対する認知行動療法の現状.最新精神医学 23:105-112, 2018
27)Matsumoto K, Ohmuro N, Tsujino N, et al:Open-label study of cognitive behavioural therapy for individuals with at-risk mental state:Feasibility in the Japanese clinical setting. Early Interv Psychiatry 13:137-141, 2019
28)Schmidt SJ, Schultze-Lutter F, Schimmelmann BG, et al:EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry 30:388-404, 2015
29)Lally J, Ajnakina O, Stubbs B, et al:Remission and recovery from first-episode psychosis in adults:systematic review and meta-analysis of long-term outcome studies. Br J Psychiatry 211:350-358, 2017